English
English
Investing in the future of AI life sciences
Investing in the future of AI life sciences
Investing in the future of AI life sciences
Investing in the future of AI life sciences
Investing in the future of AI life sciences
Investing in the future of AI life sciences
Linearis is a venture fund with a tandem, world-class metabolomics laboratory.
Investing in the future of AI life sciences
Linearis with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries to prevent, detect, and cure diseases through direct investments in innovative AI-powered life sciences companies.
Linearis with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries to prevent, detect, and cure diseases through direct investments in innovative AI-powered life sciences companies.
Linearis with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries to prevent, detect, and cure diseases through direct investments in innovative AI-powered life sciences companies.
Labs
Metabolomics Services
Disease Signatures Discovery
AI Analysis Software
Linearis Ventures
Creating impact across the entire AI-life science continuum by investing and supporting innovation in drug discovery, early diagnosis, prevention and patient monitoring.
Linearis Lab
The metabolome is where biology becomes measurable. With high-resolution metabolomics laboratory, Linearis turns metabolites into high-fidelity, reproducible data for BioPharma, CRO, biobanks, clinical and academic partners.
Linearis works alongside the institutions, research centres, and funding bodies driving the next era of life sciences innovation.
Segment
Segment
